Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy

Determination of the risk–benefit ratio associated with the use of novel coronavirus disease 2019 (COVID-19) repurposed drugs in older adults with polypharmacy is mandatory. Our objective was to develop and validate a strategy to assess risk for adverse drug events (ADE) associated with COVID-19 rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Rihani, Sweilem B., Smith, Matt K., Bikmetov, Ravil, Deodhar, Malavika, Dow, Pamela, Turgeon, Jacques, Michaud, Veronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463624/
https://www.ncbi.nlm.nih.gov/pubmed/32785135
http://dx.doi.org/10.3390/jcm9082591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463624/
https://www.ncbi.nlm.nih.gov/pubmed/32785135
http://dx.doi.org/10.3390/jcm9082591

Ejemplares similares